Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Longoni

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Urologic Oncology|April 4, 2026
Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort studyPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
BJU International|March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groupsAna Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
World Journal of Urology|October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year studyMario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
BJU International|October 6, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomyFrancesco Pellegrino, Mario de Angelis, Pietro Scilipoti, et al.
BJU International|August 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapyJosé Daniel Subiela, Irene de la Parra, Javier Taborda, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Urologic Oncology|April 4, 2026
Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort studyPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
BJU International|March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groupsAna Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
World Journal of Urology|October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year studyMario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
BJU International|October 6, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomyFrancesco Pellegrino, Mario de Angelis, Pietro Scilipoti, et al.
BJU International|August 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapyJosé Daniel Subiela, Irene de la Parra, Javier Taborda, et al.
Pageof 12